The China in-vitro diagnostics market size has the potential to grow by USD 6.93 billion during 2020-2024, and the market’s growth momentum will decelerate at a CAGR of 16.61%.
This report provides a detailed analysis of the market by end-user (hospitals, homecare, research institutes, and independent laboratories), application (immunochemistry, tissue diagnostics, molecular diagnostics, hematology, and others), and key vendors.
Market Overview
Browse TOC and LoE with selected illustrations and example pages of China In-Vitro Diagnostics Market
Market Competitive Analysis
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Agilent Technologies Inc.
- Autobio Diagnostics Co. Ltd.
- Bioptik Technology Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Healthineers AG
- Sysmex Corp.
The China in-vitro diagnostics market is fragmented and the vendors are deploying organic growth strategies to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
The market players also significantly leverage external market drivers such as an increase in incidences of chronic and infectious diseases to achieve growth opportunities. However, factors such as an increase in demand and expectations of improved healthcare facilities will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the China in-vitro diagnostics market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies,
This China in-vitro diagnostics market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities. Grab your Free Sample now to unlock further information on other key market drivers
China in-Vitro Diagnostics Market: Segmentation by End-user
Request for a FREE sample and Get more information on the market contribution of various segments
Hospitals are the major end-users of the in-vitro diagnostics market in China, as they are preferred for the diagnosis of chronic and infectious diseases. Therefore, the rising prevalence of chronic and infectious diseases and the growing trend of preventive healthcare are increasing the number of tests performed at hospitals, which is benefiting the in-vitro diagnostics market in China. However, the hospital segment will record a slow growth rate that research institutes and independent laboratories during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the China in-vitro diagnostics market size. Fetch actionable market insights on post COVID19 impact on each segment.
China in-Vitro Diagnostics Market: Key Highlights of the Report for 2020-2024
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will drive China in-vitro diagnostics market growth during the next five years
- Precise estimation of the China in-vitro diagnostics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the China in-vitro diagnostics industry
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of China in-vitro diagnostics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch